Search Orphan Drug Designations and Approvals
-
Generic Name: | satralizumab-mwge |
---|---|
Date Designated: | 07/18/2022 |
Orphan Designation: | Treatment of N-methyl-D-asparatate receptor (NMDAR) antibody autoimmune encephalitis (AIE) |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Genentech, Inc. 1 DNA Way South San Francisco, California 94080-4990 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-